Do you want to read an article? Please log in or register.
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Further Publications NeurologyFurther Publications Psychiatry